残障人士参与临床试验招募的障碍与促进因素:范围综述
本研究遵循乔安娜布里格斯研究所范围综述指南,检索MEDLINE和EMBASE数据库,纳入56篇文献,梳理残障人士参与临床试验招募的障碍与促进因素。证据多来自研究者视角短篇通讯(N=22)和原始定量研究(N=17),照护者视角少见,最常见残障类型为神经与精神障碍。共归纳五个主题:风险与获益评估、招募方案设计与管理、内部与外部效度平衡、知情同意与伦理、系统性因素。
要点
- 障碍与促进因素常高度特定于残障类型和研究情境,应减少假设。
- 研究设计应优先采用协同设计原则,并以数据驱动的需求评估为依据。
- 应采用以人为本的知情同意方式,赋权残障人士行使选择权。
核心结论
- 障碍与促进因素常高度特定于残障类型和情境,应减少假设。
- 研究设计应优先采用协同设计原则,并以数据驱动的需求评估为依据。
- 应采用以人为本的知情同意方式,赋权残障人士行使选择权,以改善临床试验研究的包容性实践。
研究设计与样本
- 遵循乔安娜布里格斯研究所(JBI)范围综述指南完成本范围综述。
- 通过Ovid检索MEDLINE和EMBASE数据库,检索由四个关键概念引导:残障人群、患者招募、障碍与促进因素、临床试验。
- 纳入讨论各类障碍与促进因素的论文,排除至少没有一个残障群体作为研究人群的论文。
- 共纳入56篇符合条件的论文。
主要发现
- 证据主要来自研究者视角短篇通讯(N=22)和原始定量研究(N=17)。
- 文章中照护者视角很少被代表。
- 文献中关注人群最常见的残障类型为神经与精神障碍。
- 共确定五个新兴主题:风险与获益评估、招募方案设计与管理、内部与外部效度平衡、知情同意与伦理、系统性因素。
临床怎么用
- 作者建议减少假设,研究设计应优先采用协同设计原则,并以数据驱动的需求评估为依据。
- 作者建议采用以人为本的知情同意方式,赋权残障人士行使选择权。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Underrepresentation of disabled groups in clinical trials results in an inadequate evidence base for their clinical care, which drives health inequalities. This study aims to review and map the potential barriers and facilitators to the recruitment of disabled people in clinical trials to identify knowledge gaps and areas for further extensive research. The review addresses the question: 'What are the barriers and facilitators to recruitment of disabled people to clinical trials?'. METHODS: The Joanna Briggs Institute (JBI) Scoping review guidelines were followed to complete the current scoping review. MEDLINE and EMBASE databases were searched via Ovid. The literature search was guided by a combination of four key concepts from the research question: (1) disabled populations, (2) patient recruitment, (3) barriers and facilitators, and (4) clinical trials. Papers discussing barriers and facilitators of all types were included. Papers that did not have at least one disabled group as their population were excluded. Data on study characteristics and identified barriers and facilitators were extracted. Identified barriers and facilitators were then synthesised according to common themes. RESULTS: The review included 56 eligible papers. The evidence on barriers and facilitators was largely sourced from Short Communications from Researcher Perspectives (N = 22) and Primary Quantitative Research (N = 17). Carer perspectives were rarely represented in articles. The most common disability types for the population of interest in the literature were neurological and psychiatric disabilities. A total of five emergent themes were determined across the barriers and facilitators. These were as follows: risk vs benefit assessment, design and management of recruitment protocol, balancing internal and external validity considerations, consent and ethics, and systemic factors. CONCLUSIONS: Both barriers and facilitators were often highly specific to disability type and context. Assumptions should be minimised, and study design should prioritise principles of co-design and be informed by a data-driven assessment of needs for the study population. Person-centred approaches to consent that empower disabled people to exercise their right to choose should be adopted in inclusive practice. Implementing these recommendations stands to improve inclusive practices in clinical trial research, serving to produce a well-rounded and comprehensive evidence base.
引用
- Shariq S, Cardoso Pinto AM, Budhathoki SS, et al. Barriers and facilitators to the recruitment of disabled people to clinical trials: a scoping review. Trials. 2023. PMID: 36890505. doi:10.1186/s13063-023-07142-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。